XDNA
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
XDNA
Delisted
XDNA was delisted on the 30th of November, 2023.
1 hedge funds and large institutions have $137K invested in Strategic Trust Kelly CRISPR & Gene Editing Technology ETF in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$65K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$53.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $137K | -$65K | -7,307 | -32% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$53.2K | -5,352 | Closed |
|